Stanford University
Showing 641-650 of 732 Results
-
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Jason V. Tso, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Tso is a board-certified cardiologist with the Sports Cardiology Program and the Center for Inherited Cardiovascular Disease. He serves as medical director of the Sports Cardiology Program and is a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine.
With clinical expertise in sports cardiology, Dr. Tso specializes in treating physically active patients. He cares for recreational weekend warriors, elite and professional athletes, and all those in between.
He has experience caring for athletes from professional sports teams and multiple National Collegiate Athletic Association (NCAA) Division I universities. Dr. Tso performs cardiac screening and consultation for multiple Bay Area sports teams and is the team cardiologist for Stanford Athletics and the San Francisco 49ers.
Dr. Tso’s research interests include cardiovascular health and adaptation in athletes. He has spent years studying American-style football players and Masters endurance athletes. He has presented his research at multiple national meetings, including the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions, Heart Failure Society of America, and American College of Sports Medicine.
Dr. Tso’s research has been published in multiple peer-reviewed journals including the Journal of the American Heart Association, the European Journal of Preventive Cardiology, and the British Journal of Sports Medicine. He also regularly serves as a reviewer for multiple cardiology and sports medicine journals. -
Minang (Mintu) Turakhia
Clinical Professor, Medicine
Current Research and Scholarly InterestsDr. Turakhia has an active clinical research program, with funding from AHA, VA, NIH, the medical device industry, and foundations. His research program aims to improve the treatment of heart rhythm disorders, with an emphasis on atrial fibrillation, by evaluating quality and variation of care, comparative and cost-effectiveness of therapies, and risk prediction. Dr. Turakhia has extensive expertise in using large administrative and claims databases for this work. His TREAT-AF retrospective study of over 500,000 patients with newly-diagnosed AF is the largest known research cohort of AF patients. He has served as study PI or chairman of several prominent single- and multicenter trials in atrial fibrillation, investigational devices for electrophysiology procedures, digital health interventions, and sensor technologies.
His other research interests include technology assessment of new device-based therapies and the impact of changing health policy and reform on the delivery of arrhythmia care. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society. -
Mirela Tuzovic, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Mirela Tuzovic is a board-certified, fellowship-trained cardiologist and medical director of the Stanford Health Care Center for Marfan Syndrome and Related Aortic Disorders. Dr. Tuzovic is also a clinical assistant professor in the Department of Medicine, Division of Cardiovascular Medicine at Stanford University School of Medicine.
Dr. Tuzovic diagnoses and treats a wide range of cardiovascular conditions, including aortic disorders, Marfan syndrome and other heritable thoracic aortic disorders, and cardiovascular disease. She also specializes in cardiovascular imaging and structural echocardiology. For each of her patients, she offers a comprehensive, personalized care plan.
Dr. Tuzovic’s research interests include the diagnosis and management of patients with aortic disease as well as cardiovascular imaging. As a structural echocardiographer, she is involved in multiple clinical trials for transcatheter valve repair and replacement through the Stanford Health Care Structural Heart Program. Her prior research focus has included echocardiography and cardio-oncology.
Dr. Tuzovic has published her research in peer-reviewed journals such as Circulation, the American Journal of Cardiology, Echocardiography, and JACC: CardioOncology.
Dr. Tuzovic is a member of the American College of Cardiology, the American Society of Echocardiography, and the Montalcino Aortic Consortium. -
Zhainib A. Amir
Ph.D. Student in Biology, admitted Autumn 2020
BioI received my B.S. in Microbiology, and M.S. in Cell and Molecular Biology from San Francisco State University. Currently, I am a Biology Ph.D. student with an emphasis in Cell, Molecular and Organismal Biology at Stanford University. I am interested in a range of topics, from cell biology to cancer immunology, however, my research interests lie primarily in understanding the cellular mechanisms at play in genetic and autoimmune diseases.
-
PJ Utz
Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.
-
Randall Vagelos, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions.
